| Product Code: ETC9690160 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Neuroblastoma Drug Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Neuroblastoma Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Neuroblastoma Drug Market - Industry Life Cycle |
3.4 Thailand Neuroblastoma Drug Market - Porter's Five Forces |
3.5 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.6 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.8 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Thailand Neuroblastoma Drug Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 Thailand Neuroblastoma Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroblastoma cases in Thailand |
4.2.2 Technological advancements in neuroblastoma drug development |
4.2.3 Growing investments in healthcare infrastructure and research for neuroblastoma treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for neuroblastoma drugs |
4.3.2 High cost associated with neuroblastoma drug development and treatment |
4.3.3 Limited awareness about neuroblastoma and its treatment options among patients and healthcare providers |
5 Thailand Neuroblastoma Drug Market Trends |
6 Thailand Neuroblastoma Drug Market, By Types |
6.1 Thailand Neuroblastoma Drug Market, By Mechanism of Action Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Mechanism of Action Type, 2021- 2031F |
6.1.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Alkylating agents, 2021- 2031F |
6.1.4 Thailand Neuroblastoma Drug Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.1.5 Thailand Neuroblastoma Drug Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.1.6 Thailand Neuroblastoma Drug Market Revenues & Volume, By Microtubule Inhibitors, 2021- 2031F |
6.1.7 Thailand Neuroblastoma Drug Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2 Thailand Neuroblastoma Drug Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Cyclophosphamide, 2021- 2031F |
6.2.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Cisplatin, 2021- 2031F |
6.2.4 Thailand Neuroblastoma Drug Market Revenues & Volume, By Vincristine, 2021- 2031F |
6.2.5 Thailand Neuroblastoma Drug Market Revenues & Volume, By Doxorubicin, 2021- 2031F |
6.2.6 Thailand Neuroblastoma Drug Market Revenues & Volume, By Etoposide, 2021- 2031F |
6.2.7 Thailand Neuroblastoma Drug Market Revenues & Volume, By Topotecan, 2021- 2031F |
6.3 Thailand Neuroblastoma Drug Market, By Diagnosis Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Physical Test, 2021- 2031F |
6.3.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Urine and Blood Test, 2021- 2031F |
6.3.4 Thailand Neuroblastoma Drug Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.5 Thailand Neuroblastoma Drug Market Revenues & Volume, By Tissue Sample Testing, 2021- 2031F |
6.3.6 Thailand Neuroblastoma Drug Market Revenues & Volume, By Bone Marrow Sample Testing, 2021- 2031F |
6.4 Thailand Neuroblastoma Drug Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.4 Thailand Neuroblastoma Drug Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.4.5 Thailand Neuroblastoma Drug Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.4.6 Thailand Neuroblastoma Drug Market Revenues & Volume, By Bone Marrow transplantation, 2021- 2031F |
6.4.7 Thailand Neuroblastoma Drug Market Revenues & Volume, By Retinoid Therapy, 2021- 2031F |
6.5 Thailand Neuroblastoma Drug Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Intravenous and others, 2021- 2031F |
6.6 Thailand Neuroblastoma Drug Market, By End- Users |
6.6.1 Overview and Analysis |
6.6.2 Thailand Neuroblastoma Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Thailand Neuroblastoma Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Thailand Neuroblastoma Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 Thailand Neuroblastoma Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Neuroblastoma Drug Market Import-Export Trade Statistics |
7.1 Thailand Neuroblastoma Drug Market Export to Major Countries |
7.2 Thailand Neuroblastoma Drug Market Imports from Major Countries |
8 Thailand Neuroblastoma Drug Market Key Performance Indicators |
8.1 Number of clinical trials conducted for neuroblastoma drugs in Thailand |
8.2 Percentage of healthcare professionals trained in neuroblastoma diagnosis and treatment |
8.3 Research and development expenditure dedicated to neuroblastoma drug development in Thailand |
9 Thailand Neuroblastoma Drug Market - Opportunity Assessment |
9.1 Thailand Neuroblastoma Drug Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.2 Thailand Neuroblastoma Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Thailand Neuroblastoma Drug Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.4 Thailand Neuroblastoma Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Thailand Neuroblastoma Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Thailand Neuroblastoma Drug Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 Thailand Neuroblastoma Drug Market - Competitive Landscape |
10.1 Thailand Neuroblastoma Drug Market Revenue Share, By Companies, 2024 |
10.2 Thailand Neuroblastoma Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here